je.st
news
Tag: phase
First Subsea installs cable connectors for Phase 2 of floating wind farm in Japan
2015-01-07 01:00:00| Power Technology
First Subsea has concluded delivery of cable connectors at the Fukushima floating offshore wind farm demonstration project in Japan for its Phase 2 development.
Oil Price Volatility To Push US Shale Industry Into Next Phase Of Consolidation And Productivity Gains
2015-01-06 01:24:38| oilandgasonline Home Page
Declining oil prices are impacting short term exploration and production (E&P) capital expenditures (CAPEX) and profitability, and will provide impetus to shift toward smart CAPEX and innovative operational expenditure (OPEX), according to new Frost & Sullivan research.
Tags: price
industry
oil
phase
MTR opens Phase II East Section of Beijing Metro Line 14
2015-01-06 01:00:00| Railway Technology
Hong Kong's Mass Transit Railway (MTR) has commissioned the 14.8km Phase II East Section of Beijing Metro Line 14 to serve commuters in the Chinese capital.
EQUATE successfully completes Turnaround & 1st phase of polyethylene debottlenecking
2015-01-04 10:37:08| Chemicals - Topix.net
EQUATE Petrochemical Company, Kuwait's first international petrochemical joint-venture, announced the successful completion of its plants' Turnaround and the first phase of the polyethylene plant debottlenecking project. With the participation of over 10,000 employees and contractors, EQUATE has realized the first of its kind international achievement by completing all operations within a record-time for petrochemical plants based on global standards.
Tags: 1st
phase
successfully
completes
Final Phase 1 data of zoptarelin doxorubicin Phase 1/2 trial published in Clinical Cancer Research
2014-12-31 17:46:02| Biotech - Topix.net
Aeterna Zentaris Inc. today announced that an article on final data for the Phase 1 portion of the ongoing Phase 1/2 trial in prostate cancer with zoptarelin doxorubicin , a hybrid molecule composed of a synthetic peptide carrier and a well-known chemotherapy agent, doxorubicin, has been published in the December issue of Clinical Cancer Research . The article outlines data previously disclosed in June 2013 at the American Society of Clinical Oncology's Annual Meeting, which demonstrated the compound's safety profile and promising anti-tumor activity in heavily pretreated men with castration- and taxane-resistant prostate cancer.
Tags: data
research
final
published
Sites : [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] next »